Susanne Ellfors-Zetterlund new Chief Medical Officer (CMO) at Scandinavian Biopharma
We welcome paediatrician and general practitioner Susanne Ellfors Zetterlund as our new Chief Medical Officer. Throughout Susanne’s professional life preventing disease before it occurs, has been the common thread. Susanne most recently came from a position as CMO at Werlabs, where they prevent lifestyle-related diseases through regular health checks. Prior to that, she worked as Medical Manager at Novo Nordisk with a focus on type 2 diabetes and as a medical advisor for GSK’s vaccine portfolio. Vaccines were also a central part of Susanne’s job as a school chief physician and child health chief physician at Region Skåne.
– I have always been passionate about prevention. To actively prevent disease from occurring in a healthy individual or to prevent a condition from getting worse. Everyone benefits from preventive work, both the individual, the healthcare system and society at large. Vaccination is one of the most effective medical measures to prevent disease. It pains me to see that millions of children still die every year due to diarrhoeal diseases that can be prevented with vaccines. In my role as CMO at Scandinavian Biopharma, I hope to be able to contribute to the development of an ETEC vaccine that can meet this great medical need. We can really make a difference, especially for children under five in low- and middle-income countries who do not enjoy the same privileged conditions that we do, says Susanne Ellfors-Zetterlund
– I am very pleased to welcome Susanne to Scandinavian Biopharma. Her long experience from both the pharmaceutical and healthcare industries suit us perfectly. Her expertise will come in handy during the final testing and later during the expected launch of our diarrhoea vaccine ETVAX®. Susanne will also support our distribution business, says Björn Sjöstrand, CEO of Scandinavian Biopharma.
Susanne Ellfors-Zetterlund Chief Medical Officer at Scandinavian Biopharma
